A Combined Oral Contraceptive Containing 3-mg Drospirenone/20-µg Ethinyl Estradiol in the Treatment of Acne Vulgaris: A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessment

Article Type
Changed
Thu, 01/10/2019 - 12:15
Display Headline
A Combined Oral Contraceptive Containing 3-mg Drospirenone/20-µg Ethinyl Estradiol in the Treatment of Acne Vulgaris: A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessment

Article PDF
Author and Disclosure Information

Lucky AW, Koltun W, Thiboutot D, Niknian M, Sampson-Landers C, Korner P, Marr J

Issue
Cutis - 82(2)
Publications
Topics
Page Number
143-150
Sections
Author and Disclosure Information

Lucky AW, Koltun W, Thiboutot D, Niknian M, Sampson-Landers C, Korner P, Marr J

Author and Disclosure Information

Lucky AW, Koltun W, Thiboutot D, Niknian M, Sampson-Landers C, Korner P, Marr J

Article PDF
Article PDF

Issue
Cutis - 82(2)
Issue
Cutis - 82(2)
Page Number
143-150
Page Number
143-150
Publications
Publications
Topics
Article Type
Display Headline
A Combined Oral Contraceptive Containing 3-mg Drospirenone/20-µg Ethinyl Estradiol in the Treatment of Acne Vulgaris: A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessment
Display Headline
A Combined Oral Contraceptive Containing 3-mg Drospirenone/20-µg Ethinyl Estradiol in the Treatment of Acne Vulgaris: A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessment
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media